Difference between revisions of "Dihydroergocristine"
From Self-sufficiency
m (robot Adding: pt:Di-hidroergocristina) |
m (1 revision) |
(No difference)
|
Latest revision as of 15:48, 19 September 2010
Dihydroergocristine | |
---|---|
File:Dihydroergocristine.svg | |
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-2,6-dimethyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide | |
Other names (5′a,10a)-9,10-Dihydro-12′- hydroxy-2′-(1-methylethyl)-5′-(phenylmethyl)ergotaman-3′,6′,18-trione | |
style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
CAS number | 17479-19-5 |
PubChem | 3065 |
ChemSpider | 96884 |
IUPHAR ligand | 278 |
SMILES | Script error: No such module "collapsible list". |
InChI | Script error: No such module "collapsible list". |
style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
Molecular formula | C35H41N5O5 |
Molar mass | 611.73 g/mol |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
Infobox references |
Dihydroergocristine is an ergot alkaloid. Alongside dihydroergocornine and dihydroergocryptine, it is one of the components of ergoloid.
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |